Chan, E., Luwor, R., Burns, C., Kannourakis, G., Findlay, J. K., & Ahmed, N. (2018). Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer. Oncotarget.

Chan, Emily, Rodney Luwor, Christopher Burns, George Kannourakis, Jock K. Findlay, and Nuzhat Ahmed. "Momelotinib Decreased Cancer Stem Cell Associated Tumor Burden and Prolonged Disease-free Remission Period in a Mouse Model of Human Ovarian Cancer." Oncotarget 2018.

Chan, Emily, et al. "Momelotinib Decreased Cancer Stem Cell Associated Tumor Burden and Prolonged Disease-free Remission Period in a Mouse Model of Human Ovarian Cancer." Oncotarget 2018.